Exp Clin Endocrinol Diabetes 1993; 101(6): 360-364
DOI: 10.1055/s-0029-1211258
Original

© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Insulin Action in Patients with Insulinoma Influenced by Pharmacological and Surgical Therapy

J. Škrha, J. Hilgertová, V. Justová
  • Department of Internal Medicine 3, Laboratory for Endocrinology and Metabolism, Faculty of Medicine, Charles University, Prague, Czech Republic
Further Information

Publication History

Publication Date:
15 July 2009 (online)

Summary

Organic hyperinsulinism due to insulinoma is accompanied by changes of insulin action on receptor and postreceptor levels. The influence of conservative and surgical treatment on insulin sensitivity was examined by euglycaemic hyperinsulinaemic clamps in ten patients with insulinoma. The “responders” (n = 5) and “non-responders” (n = 5) to diazoxide treatment were distinguished by using fasting plasma glucose and insulin concentrations.

The index of insulin sensitivity was significantly decreased in pretreated “responders” as compared to healthy persons (19±3 vs 39 ±6 and 20±3 vs 37± 5μmol.kg−1.min−1per mU.1−1× 100, p<0.01) and it was improved during diazoxide administration (27±4 vs 19 ±3 and 35 ± 12 vs 20±3μmol. kg−1. min−1 per mU.1 −1 × 100, p<0.05). Significantly decreased insulin sensitivity in pretreated “non-responders” (25±5 vs 39 ±6 and 28±6 vs 37 ±5 μmol.kg−1.min−1 per mU.1−1 × 100, p<0.05) was not improved by diazoxide administration. Metabolic clearance rate of glucose was significantly higher in “non-responders” as compared to “responders” and healthy persons (12.7 ± 3.4 vs 7.9 ±2.7 and 7.4±2.4ml.min−1.kg−1, p<0.05) already in pretreated state. An inverse relationship was found between metabolic clearance rate of glucose and of insulin (r = 0.72, p< 0.001). Plasma glucose, insulin concentration, index of insulin sensitivity, and metabolic clearance rate of glucose and of insulin were normalized after surgical removal of an insulinoma in all patients. We conclude that euglycaemic clamps may be used in patients with insulinoma to consider the reliability of diazoxide therapy.

    >